Role of endogenous opioids in neurohypophysial function of man.

@article{Miller1980RoleOE,
  title={Role of endogenous opioids in neurohypophysial function of man.},
  author={M. Miller},
  journal={The Journal of clinical endocrinology and metabolism},
  year={1980},
  volume={50 6},
  pages={
          1016-20
        }
}
  • M. Miller
  • Published 1980
  • Medicine, Chemistry
  • The Journal of clinical endocrinology and metabolism
    • Studies were carried out in normal human subjects to determine the effect of two narcotic antagonists, oxilorphan and butorphanol, on antidiuretic hormone (ADH) release. Oxilorphan given to eight subjects on ad libitum fluid intake resulted in a transient but significant increase in 24-h free water clearance and a decrease in urine osmolality. These changes were not accompanied by an increase in creatinine or solute excretion, and urinary ADH levels did not rise even though plasma osmolality… CONTINUE READING
    View on PubMed
    academic.oup.com
    34 Citations
    Background Citations
    3
    34 Citations
    Citation Type

    Citation Type

    Evidence for a role of opioid peptides in the release of arginine vasopressin in the conscious rat.
    • 24
    • PDF
    Neurogenic disorders of osmoregulation.
    • 298
    Pituitary and adrenal hormone responses to naloxone in euhydrated and dehydrated dogs.
    • C. Wade
    • Chemistry, Medicine
    • The American journal of physiology
    • 1985
    • 6
    Action of cortisol introduced into the supraoptic nucleus, on vasopressin release and antidiuresis during hypertonic saline infusion in conscious rhesus monkeys.
    • 7
    • PDF
    Neuroendocrine effects of endogenous opioid peptides in human subjects: A review
    • J. Morley
    • Biology, Medicine
    • Psychoneuroendocrinology
    • 1983
    • 83
    Brain opiates and neuroendocrine function.
    • A. Grossman
    • Medicine
    • Clinics in endocrinology and metabolism
    • 1983
    • 95
    Psychoneuroendocrine effects of methadone maintenance
    • 46
    Clinical Pharmacokinetics of Narcotic Agonist-Antagonist Drugs
    • 69
    Regulation of vasopressin release by neurotransmitters, neuropeptides and osmotic stimuli.
    • C. Sladek
    • Chemistry, Medicine
    • Progress in brain research
    • 1983
    • 82
    Thirst and Vasopressin
    • 3

    References

    SHOWING 1-10 OF 18 REFERENCES
    Inhibition of ADH release in the rat by narcotic antagonists.
    • M. Miller
    • Biology, Medicine
    • Neuroendocrinology
    • 1975
    • 42
    Studies on the antidiuretic action of morphine in the rat.
    • 25
    Diuretic action of the narcotic antagonist oxilorphan
    • 25
    THE ANTIDIURETIC ACTION OF MORPHINE, AND ITS MECHANISM
    • 146
    Quantitative influence of blood volume expansion on the osmotic threshold for vasopressin release.
    • 40
    The antidiuretic action of morphine: its site and mode of action in the hypothalamus of the dog.
    • 59
    Involvement of brain serotonin in the prolactin-releasing effect of opioid peptides.
    • 82
    Radioimmunoassay of urinary antidiuretic hormone with application to study of the Brattleboro rat.
    • 64
    Leu-enkephalin-stimulated growth hormone and prolactin release in the rat: comparison with the effect of morphine.
    • 77
    Stimulation in vivo of the secretion of prolactin and growth hormone by beta-endorphin.
    • 399